Search hospitals > Connecticut > New Haven
Yale Cancer Center
Claim this profileNew Haven, Connecticut 06510
Global Leader in Cancer
Global Leader in Solid Tumors
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lymphoma
408 reported clinical trials
39 medical researchers
Summary
Yale Cancer Center is a medical facility located in New Haven, Connecticut. This center is recognized for care of Cancer, Solid Tumors, Breast Cancer, Non-Small Cell Lung Cancer, Lymphoma and other specialties. Yale Cancer Center is involved with conducting 408 clinical trials across 312 conditions. There are 39 research doctors associated with this hospital, such as Patricia M Lorusso, Alessandro Santin, Amer M. Zeidan, and Joseph W. Kim, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
MSI-H positive
2Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
Top PIs
Patricia M LorussoYale Cancer Center6 years of reported clinical research
Expert in Cancer
Expert in Solid Tumors
27 reported clinical trials
43 drugs studied
Alessandro SantinSmilow Cancer Hospital at Yale New Haven5 years of reported clinical research
Studies Ovarian Cancer
Studies Endometrial Cancer
17 reported clinical trials
25 drugs studied
Amer M. ZeidanYale Cancer Center4 years of reported clinical research
Expert in Myelodysplastic Syndrome
Expert in Adult T-Cell Leukemia/Lymphoma
17 reported clinical trials
27 drugs studied
Joseph W. Kim, MDYale University8 years of reported clinical research
Studies Parotid Gland Cancer
Studies Prostatic Neoplasm
14 reported clinical trials
27 drugs studied
Clinical Trials running at Yale Cancer Center
Cancer
Solid Tumors
Breast Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Ovarian Cancer
Lymphoma
Lung Cancer
Pancreatic Cancer
Prostatic Neoplasm
Immunotherapy + Radiation
for Head and Neck Cancer
The purpose of this study is to compare any good or bad effects of using pembrolizumab (an experimental drug) and radiation therapy (RT), compared to using cisplatin chemotherapy and radiation therapy (RT) in the treatment of patients with head and neck squamous cell carcinoma (HNSCC).
Recruiting2 awards Phase 2
RYZ101
for Neuroendocrine Tumors
This trial tests RYZ101, a new drug, in patients with advanced GEP-NETs that haven't responded to previous treatments. The drug aims to target specific receptors on the tumor cells to stop their growth.
Recruiting2 awards Phase 312 criteria
TTX-080 +/− Cetuximab/Pembrolizumab
for Cancer
This trial tests TTX-080, a new drug, alone and with other cancer drugs in patients with hard-to-treat cancers. It works by helping the immune system find and attack cancer cells.
Recruiting1 award Phase 14 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Yale Cancer Center?
Where is Yale Cancer Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Yale Cancer Center accept?
What awards or recognition has Yale Cancer Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.